Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Ando

Showing results (91-100 of 127) with videos related to

Pageof 13
Sort By:
Heliyon|August 30, 2021
Trigenic <i>ADH5</i>/<i>ALDH2</i>/<i>ADGRV1</i> mutations in myelodysplasia with Usher syndromeShintaro Kinoshita, Miki Ando, Jun Ando, et al.
Oncology and Therapy|March 7, 2025
Real-World Experience with Venetoclax Treatment for Newly-Diagnosed Acute Myeloid Leukemia in Japan (VENUS Study): An Interim Analysis Focusing on Neutropenia ManagementTatsunori Goto, Hiroki Numata, Yuna Katsuoka, et al.
Case Reports in Oncology|April 18, 2022
Hodgkin Lymphoma on Hemodialysis Successfully Treated with Extended Courses of Brentuximab VedotinAyana Uchimura, Hajime Yasuda, Jun Ando, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2017
Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T CellsMiyuki Tanaka, Haruko Tashiro, Bilal Omer, et al.
International Journal of Hematology|November 7, 2025
Real-world outcomes of venetoclax and azacitidine in Japanese patients with newly diagnosed acute myeloid leukemia (VENUS study)Ryota Imanaka, Hiroki Numata, Yuna Katsuoka, et al.
Cancer Research Communications|February 21, 2024
Rejuvenated iPSC-derived GD2-directed CART Cells Harbor Robust Cytotoxicity Against Small Cell Lung CancerShintaro Kinoshita, Midori Ishii, Jun Ando, et al.
Biochemistry and Biophysics Reports|August 12, 2021
SCLC-J1, a novel small cell lung cancer cell lineKazuo Ohara, Shintaro Kinoshita, Jun Ando, et al.
Communications Biology|April 20, 2021
Amplification-free RNA detection with CRISPR-Cas13Hajime Shinoda, Yuya Taguchi, Ryoya Nakagawa, et al.
Leukemia Research|June 11, 2022
Clinical and biological relevance of CREB3L1 in Philadelphia chromosome-negative myeloproliferative neoplasmsFederico De Marchi, Maho Okuda, Soji Morishita, et al.
European Journal of Haematology|September 21, 2022
von Willebrand factor activity levels are influenced by driver mutation status in polycythemia vera and essential thrombocythemia patients with well-controlled platelet countsKazuhide Iizuka, Soji Morishita, Yuji Nishizaki, et al.
Pageof 13

Showing results (91-100 of 127) with videos related to

Sort By:
Pageof 13
Heliyon|August 30, 2021
Trigenic <i>ADH5</i>/<i>ALDH2</i>/<i>ADGRV1</i> mutations in myelodysplasia with Usher syndromeShintaro Kinoshita, Miki Ando, Jun Ando, et al.
Oncology and Therapy|March 7, 2025
Real-World Experience with Venetoclax Treatment for Newly-Diagnosed Acute Myeloid Leukemia in Japan (VENUS Study): An Interim Analysis Focusing on Neutropenia ManagementTatsunori Goto, Hiroki Numata, Yuna Katsuoka, et al.
Case Reports in Oncology|April 18, 2022
Hodgkin Lymphoma on Hemodialysis Successfully Treated with Extended Courses of Brentuximab VedotinAyana Uchimura, Hajime Yasuda, Jun Ando, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2017
Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T CellsMiyuki Tanaka, Haruko Tashiro, Bilal Omer, et al.
International Journal of Hematology|November 7, 2025
Real-world outcomes of venetoclax and azacitidine in Japanese patients with newly diagnosed acute myeloid leukemia (VENUS study)Ryota Imanaka, Hiroki Numata, Yuna Katsuoka, et al.
Cancer Research Communications|February 21, 2024
Rejuvenated iPSC-derived GD2-directed CART Cells Harbor Robust Cytotoxicity Against Small Cell Lung CancerShintaro Kinoshita, Midori Ishii, Jun Ando, et al.
Biochemistry and Biophysics Reports|August 12, 2021
SCLC-J1, a novel small cell lung cancer cell lineKazuo Ohara, Shintaro Kinoshita, Jun Ando, et al.
Communications Biology|April 20, 2021
Amplification-free RNA detection with CRISPR-Cas13Hajime Shinoda, Yuya Taguchi, Ryoya Nakagawa, et al.
Leukemia Research|June 11, 2022
Clinical and biological relevance of CREB3L1 in Philadelphia chromosome-negative myeloproliferative neoplasmsFederico De Marchi, Maho Okuda, Soji Morishita, et al.
European Journal of Haematology|September 21, 2022
von Willebrand factor activity levels are influenced by driver mutation status in polycythemia vera and essential thrombocythemia patients with well-controlled platelet countsKazuhide Iizuka, Soji Morishita, Yuji Nishizaki, et al.
Pageof 13